mike_mod said:Denials are usually procedural rather than clinical, and the order that works reflects that.
Financial impact of cost and coverage weight loss beyond medication cost:
- Groceries: SAVED $245/month (eating less)
- Restaurants: SAVED $175/month (fewer meals out)
- Alcohol: SAVED $125/month (stopped drinking)
- Life insurance: Premium REDUCED by $35/month (lower BMI)
- Copays: SAVED $65/month (fewer BP/cholesterol meds)
Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.
One thing that is still open after newstart_MO’s answer:
Did your prescriber agree with that reading, and if not what was their objection?
josh_phd_bmore said:Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $245/month (eating less) Restaurants: SAVED $175/month…
josh_phd_bmore said:...regarding the discontinuation data for cost and coverage...
I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."
Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.
This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemReporting back.
Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.
sarah_TO said:josh_phd_bmore said: ...regarding the discontinuation data for cost and coverage...
Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:
- Prior authorization appeal with peer-to-peer review
- Manufacturer copay card (for commercial insurance)
- Patient assistance programs (Novo Nordisk, Eli Lilly)
- Compounded medication from a 503B pharmacy ($122/month)
- Canadian pharmacy (requires prescription, ~40-60% savings)
Don't let cost prevent access to effective treatment. There are options at every price point.